Development of brain metastases in patients with metastatic melanoma while receiving ipilimumab

Pathologic and gene expression features of metastatic melanomas to the brain

(2013) Ronald Hamilton et al.   CANCER

Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology

(2013) Ozge Gumusay et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Targeting Brain Metastases in Patients with Melanoma

(2013) Dionysis Papadatos-Pastos et al.   Biomed Research International

Ipilimumab and radiation therapy for melanoma brain metastases

(2013) Ann W. Silk et al.   Cancer Medicine

International trends in the incidence of malignant melanoma 1953-2008-are recent generations at higher or lower risk?

(2012) Friederike Erdmann et al.   INTERNATIONAL JOURNAL OF CANCER

Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival

(2012) Jonathan P. S. Knisely et al.   JOURNAL OF NEUROSURGERY

Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial

(2012) Anna Maria Di Giacomo et al.   LANCET ONCOLOGY

Ipilimumab: A novel immunostimulatory monoclonal antibody for the treatment of cancer

(2011) Grazia Graziani et al.   PHARMACOLOGICAL RESEARCH

Predictive Factors for the Development of Brain Metastasis in Advanced Unresectable Metastatic Melanoma

(2010) Agop Y. Bedikian et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Prognostic factors for survival in melanoma patients with brain metastases

(2010) Michael A. Davies et al.   CANCER

Local Radiation Therapy Inhibits Tumor Growth through the Generation of Tumor-Specific CTL: Its Potentiation by Combination with Th1 Cell Therapy

(2010) Tsuguhide Takeshima et al.   CANCER RESEARCH

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Brain and leptomeningeal metastases from cutaneous melanoma: Survival outcomes based on clinical features

(2008) Jeffrey J. Raizer et al.   NEURO-ONCOLOGY